down arrow

Metropolis Healt

  • Market Cap: Mid Cap
  • Industry: Hospital & Healthcare Services
  • ISIN: INE112L01020
  • NSEID: METROPOLIS
  • BSEID: 542650
INR
1,577.70
4.2 (0.27%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 62.84 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Metropolis Healthcare Ltd stock-summary
stock-summary
Metropolis Healthcare Ltd
Mid Cap
Hospital & Healthcare Services
Dr. Sushil Kanubhai Shah, one of the Promoters, commenced pathology business in January 1980 as a partnership firm in the name of Dr. V. K. Desai's Hospital, having Dr. Kanubhai M. Shah, Dr. Sushil Kanubhai Shah and Dr. Vasant Kalyandas Desai as partners. The partnership was continued by Dr. Sushil Kanubhai Shah, Dr. Kanubhai M. Shah and Dr. Duru Sushil Shah from September 30, 1981 onwards. In June 1989, upon death of Dr. Kanubhai M. Shah, the partnership was continued by Dr.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 10.25 Cr
Number of Shares
5.12 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
13-Apr-2024
5.12
10.25
1945
2
Issued under ESOP Scheme
15-Jan-2024
5.12
10.25
3267
2
Issued under ESOP Scheme
10-Oct-2023
5.12
10.24
2888
2
Issued under ESOP Scheme
12-Jul-2023
5.12
10.24
9884
2
Issued under ESOP Scheme
13-Apr-2023
5.12
10.24
158
2
Issued under ESOP Scheme
13-Apr-2023
5.12
10.24
158
2
Issued under ESOP Scheme
07-Jan-2023
5.12
10.24
4372
2
Issued under ESOP Scheme
13-Oct-2022
5.12
10.24
6043
0
Issued under ESOP Scheme
13-Oct-2022
5.12
10.24
6043
2
Issued under ESOP Scheme
14-Jul-2022
5.12
10.24
25502
0
Issued under ESOP Scheme
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

1.1845

Mutual Funds

Held by 27 Schemes (26.37%)

FIIs

Held by 159 FIIs (16.73%)

Promoter with highest holding

Metz Advisory Llp (30.61%)

Highest Public shareholder

Hdfc Mutual Fund - Hdfc Focused 30 Fund (9.71%)

Individual Investors Holdings

3.34%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Sushil Kanubhai Shah
Chairman & Exec. Director
1.8 cr
Ameera Sushil Shah
Managing director
5.24 cr
VIVEK GAMBHIR
Independent Director
11.9 lacs
Sanjay Bhatnagar
Independent Director
7.65 lacs
MILIND SHRIPAD SARWATE
Independent Director
18.05 lacs
Anita Ramachandran
Independent Director
11.5 lacs
Hemant Sachdev
Non-Exec & Non-Independent Dir
0
Neha Shah
Company Sec. & Compli. Officer
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Raw Materials Consumed
252.6739
0%
 
100
Raw Materials Consumed
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pathology and Diagnostic Services
580.20
99.83%
Other Operating Revenue - Sundry Balances Written Back
1.01
0.17%
 
99.83
Pathology and Diagnostic Services
0.17
Pathology and Diagnostic Services
0.17
Other Operating Revenue - Sundry Balances Written Back
99.83
Other Operating Revenue - Sundry Balances Written Back
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
323 Cr
(Quarterly Results - Dec 2024)
Net Profit:
31 Cr
stock-summary
Industry

Hospital & Healthcare Services

stock-summary
Market cap

INR 8,091 Cr (Mid Cap)

stock-summary
P/E

53.00

stock-summary
Industry P/E

55

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

12.50%

stock-summary
Price to Book

6.82